FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans
Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
The artificial pancreas can provide value to the health system.
The FDA rejected an outcomes update to the Januvia label; digital-health funding dropped in Q1 of 2017; the FDA approves 23andMe's genetic test
Darine Ghanem is head of the scientific communications excellence group at Roche.
Deborah Estrin is co-founder of Open mHealth.
Sean Duffy is CEO of Omada Health.
Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
Sanofi to sell five OTC drugs to Ipsen; Teva reports 33% revenue growth in Q4; Regeneron issued subpoena about support of nonprofits
The company acquired Everyday Health in December.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Transportation barriers can limit patient involvement in clinical trials.
A recent CME course using Facebook Live generated 34,000 views and 600 comments.
The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.
The Roche veteran says that people who work in digital health need to touch others in a meaningful way.
The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.
As digital-health funding increases, here's how VR, nanotechnology, and 3D printing could potentially improve the value of healthcare.
While VR is only just getting started, some marketers are already embracing its potential to offer an immersive experience for far-off future campaigns.
More acquisitions, less IPOs, and more non-traditional stakeholders are among key findings from StartUp Health and Rock Health about the state of digital health funding.
Judges loved the strategy and the comprehensive suite of support available across platforms for the Quitter's Circle.